'White hat bias' (WHB) (bias leading to distortion of information in the service of what may be perceived to be righteous ends) is documented through quantitative data and anecdotal evidence from the research record regarding the postulated predisposing and protective effects of nutritively sweetened beverages and breastfeeding, respectively, on obesity. Evidence of an apparent WHB is found in a degree sufficient to mislead readers. WHB bias may be conjectured to be fuelled by feelings of righteous zeal, indignation toward certain aspects of industry or other factors. Readers should beware of WHB, and our field should seek methods to minimize it.
Introduction
Scientific dialogue is dependent on fair and open presentation of data and evidence, yet concerns have been raised in recent years about bias in research practice. We present data and examples pertinent to a particular bias, a 'white hat bias' (WHB), which we define to be bias leading to distortion of research-based information in the service of what may be perceived as righteous ends. We evaluate WHB in the context of two illustrative obesity topics, nutritively sweetened beverage (NSB) consumption as a postulated risk factor 1 and breastfeeding as a postulated protective factor. 2 
Example 1FData on citation bias
If secondary reportings of original research misleadingly cite papers with statements that inaccurately describe available evidence, then inaccurate beliefs may inappropriately influence clinical practice, public policy or future research. Previously, 3 we observed that two papers 4, 5 had both statistically and non-statistically significant results on body weight, body mass index (BMI) or overweight/obesity status, which allowed future writers to potentially choose which results to cite, and were also widely cited, permitting a quantitative analysis of citations.
Cited versus citing papers
A Web of Science search (through to October 2008) yielded 195 and 45 papers citing James et al. 4 and Ebbeling et al., 5 respectively. We analyzed those in English (165 and 41, respectively). James et al. 4 studied an intervention to decrease NSB consumption and adiposity among children. Dichotomized (overweight or obese versus neither overweight nor obese) and continuous (change in BMI) data were analyzed for statistical significance. The authors wrote:
'After 12 months there was no significant change in the difference in body mass index (mean difference 0.13, À0.08-0.34) or z score (0.04, À0.04-0.12). At 12 months the mean percentage of overweight and obese children increased in the control clusters by 7.5%, compared with a decrease in the intervention group of 0.2% (mean difference 7.7%, 2.2-13.1%).'
Ebbeling et al. Data coding and analysis Each paper citing either James et al. 4 or Ebbeling et al.
5
was categorized (see Tables 1 and 2 ) on the basis of how authors cited results related to body weight, BMI or overweight/obesity outcomes from these two papers in their report. Papers citing James et al. were independently coded by the authors of this paper (DBA or MBC). Any discrepancies were resolved by discussion. Papers citing Ebbeling et al.
were scored by DBA and cross-checked by MBC. Proportions (with confidence intervals) were calculated (Tables 1 and 2 ). Exact binomial calculation tested the null hypothesis that the proportion citing papers in a misleading manner that exaggerated the strength of evidence was equal to the proportion citing papers in a misleading manner that diminished the strength of evidence; as such an equal proportion would suggest a lack of bias in the overall literature, even if not in any one paper.
Citation analysis results
Results were quite consistent across papers citing either James et al. 4 or Ebbeling et al. 5 The majority, 84.3% for James et al. 4 and 66.7% for Ebbeling et al., 5 described results in a misleadingly positive manner to varying degrees (that is, exaggerating the strength of the evidence that NSB reduction showed beneficial effects on obesity outcomes). Some were blatantly factually incorrect in their misleading statements, describing the result as showing an effect for a continuous obesity outcome, when no statistically significant effect for continuous obesity outcomes was observed. In contrast, only four papers (3.5%) were negatively misleading (that is, underplayed the strength of evidence) for James et al. 4 and none were negatively misleading for Ebbeling et al.
5
Only 12.7 and 33% of papers accurately described complete overall findings related to obesity outcomes from James et al. 4 and Ebbeling et al., 5 respectively.
To test whether the proportion of misleading reporting in the positive direction was equal to the proportion in the negative direction, we calculated the confidence interval on the proportion of misleading reportings in either direction that was positively misleading. This yields a proportion of 0.96 (95% CI: 0.903-0.985) for those citing James et al. 4 and 1.00 (95% CI: .832-1.000) for those citing Ebbeling et al.
and is significantly different from 
Example 2FData on publication bias

NSB consumption
A meta-analysis on NSB consumption and obesity 6 found that estimated adverse associations were significantly smaller (that is, less adverse) among industry-funded than among non-industry-funded studies. One troubling conceivable explanation for this is that industry does something to bias results to make NSBs seem less harmful, but this is not the only conceivable explanation.
To examine this further, we requested, and Dr Vartanian 6 graciously provided, his meta-analysis data file. Focusing on cross-sectional studies, because a large number had adiposity indicators as outcomes, we conducted publication bias (PB) detection analyses. 7 PB causes the sample of studies published to not constitute a representative sample of the relevant studies that hypothetically could have been FDescribed the result of the intervention study as not showing efficacy, benefit or statistical significance on some weight-related outcome without explicitly stating that it was on the continuous measure of BMI. (G) Explicitly misleading (negatively)FDescribed, with a factually incorrect statement, that the result for the dichotomous outcome was not significant or that a lack of effectiveness was shown for the dichotomous outcome. (H) UnscorableFDid not make explicit statements about the effects of the study, made statements that were too ambiguous to code or made statements that were self-contradictory.
White hat bias MB Cope and DB Allison published. With PB, the probability of a study being published depends on its outcome. Typically, PB involves statistically significant studies having a higher likelihood of being published than non-statistically significant ones. Our analysis ( Figure 1) shows a clear inverse association between study precision and association magnitude. This PB hallmark suggests that studies with statistically significant NSB findings are more likely to be published than are nonstatistically significant ones. Interestingly, this bias seems to be present only for non-industry-funded research, suggesting that non-industry-funded scientists tend not to publish their non-significant associations in this area. Contrarily, all industry-funded studies seem to exceed a minimal level of precision. Thus, much of the reason for the smaller associations detected by Vartanian et al. 6 for industry-funded research seems to be because of PB in non-industry-funded research. However, even after accounting for precision, the mean difference between the association magnitudes of industry and non-industry-funded studies is reduced by 33%, but not eliminated, suggesting that there may be competing biases operating in industry-funded research.
Breastfeeding
The World Health Organization (WHO; 8 ) published a metaanalysis on whether breastfeeding protects against obesity and also found evidence of PB. Figure 2 indicates this strikingly. We retrieved all papers from which data were obtained for Figure 2 to evaluate the impact of industry funding on this PB. None of the papers reported any industry funding or were obviously authored by authors employed by the infant formula industry. Thus, as with the NSB literature, there seems to be a strong PB that is not apparently fueled by industry interests.
Example 3FAnecdotal examples of miscommunications in press releases
Evidence suggests that 'Press releases from academic medical centers often promote research that has uncertain relevance to human health and do not provide key facts or acknowledge important limitations'. 9 This is also occurring in the obesity field. For example, the paper by Ebbeling et al. states, 'change in body mass index (BMI) was the primary end point. The net difference, 0.14±0.21 kg/m 2 , was not significant overall,' and then reports the subgroup finding, 'Among the subjects in the upper baseline-BMI tertile, BMI White hat bias MB Cope and DB Allison change differed significantly between the interventionyand controlygroups.' Contrast this modest finding in a sample subset and the circumspect presentation in the original paper with the presentation in the press release issued by the authors' institution (http://www.childrenshospital. org/newsroom/Site1339/mainpageS1339P1sublevel192.html (accessed on 31 October 2008)), which states 'In randomized trial, a simple beverage-focused intervention led to weight loss' and never states that the primary analysis was not statistically significant.
When the paper by James et al. 4 was released, the press release issued on the BMJ website (http://www.bmj.com/ content/vol328/issue7446/press_release.shtml (accessed on 20 September 2009)) stated 'Discouraging children from drinking fizzy drinks can prevent excessive weight gain, according to new research available on bmj.com,' despite the facts that no analysis of weight change per se was reported and that there was no significant effect on BMI change. Neither of these facts was mentioned in the press release. Finally, in 2009, describing an observational epidemiological study, UCLA issued a press release (http:// www.healthpolicy.ucla.edu/NewsReleaseDetails.aspx?id ¼ 35 (accessed on 20 September 2009)) stating 'yresearch released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California's expanding girth' One of the study authors was quoted in a subsequent news story stating 'For the first time, we have strong scientific evidence that soda is one of theFif not the largestFcontributors to the obesity epidemic' (http://www.drcutler.com/poor-diet/ study-soda-making-californians-fat-19373657/ (accessed on 25 September 2009)). These statements are inaccurate and also unfair to all authors of observational studies who published such research years before. The press release further stated 'The science is clear and conclusive [emphasis added],' despite the fact that this was a correlational research, and offered no statement to the reader to interpret the results as indicative of correlation and not necessarily causation.
Example 4FInappropriate or questionable inclusion of information
Research may also be misleadingly presented by inclusion of incorrect or questionable material in reviews. In our critical review of the WHO report on breastfeeding, we noted several examples (see, Cope To the extent that such comparisons inform us about important causes of obesity and how to reduce them, this is all to the good. But to the extent that such comparisons and other appeals to passions inflame rather than inform, they may cloud judgment and decrease inhibitions against breaching ordinary rules of conduct. Historians indicate that during times of war, propagandists demonize (that is, dehumanize) the enemy to inflame spirits and this facilitates some breaches of codes of conduct such as massacres. 12 Although inflaming the passions of scientists interested in public health is unlikely to provoke bloodshed, we scientists have, as a discipline, our own code of conduct. Central to it is a commitment to faithful reporting, to acknowledging our study limitations, to evaluating bodies of evidence without selectively excluding information on the basis of its desirabilityFin short, a commitment to truthfulness. The demonization of some aspects and sanctification of others, although perhaps helpful in spurring social action, may be more harmful to us in the long run by giving unconscious permission to breach that code, thereby eroding the foundation of scientific discipline.
Evidence presented herein suggests that at least one aspect has been demonized (NSB consumption) and another sanctified (breastfeeding), leading to bias in the presentation of research literature to other scientists and to the public at large, a bias sufficient to misguide readers. Interestingly, although many papers point out what seem to be biases resulting from industry funding, we have identified here, perhaps for the first time, clear evidence that WHBs can also exist in opposition to industry interests.
Whether WHB is intentional or unintentional, and whether it stems from a bias toward anti-industry results, significant findings, feelings of righteous indignation, results that may justify public health actions, or yet other factors, is unclear. Future research should study approaches to minimize such distortions in the research record. We suggest that authors be more attentive to reporting primary results from earlier studies rather than selectively including only a part of the results, to avoiding PB, as well as to ensuring that their institutional press releases are commensurate with the studies described. Journal editors and peer reviewers should also be vigilant and seek to minimize WHB. Clinicians, media, public health policy makers and the public should also be cognizant of such biases and view the literature on NSBs, breastfeeding and other obesity-related topics more critically.
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